Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Alkermes plc - Ordinary Shares (NQ:ALKS)

30.04 -1.05 (-3.38%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,317,117
Open 31.22
Bid (Size) 30.05 (2)
Ask (Size) 30.65 (10)
Prev. Close 31.09
Today's Range 29.93 - 31.22
52wk Range 25.16 - 36.45
Shares Outstanding 166,121,384
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Breaking Down Alkermes: 8 Analysts Share Their Views
 
Via Benzinga
Alkermes Strikes $2.1 Billion Avadel Deal, Gains Access To Narcolepsy Drug Lumryz
Alkermes agrees to acquire Avadel for $2.1 billion, adding the successful Lumryz drug and accelerating entry into sleep medicine. Jazz litigation settled. 
Via Benzinga

Performance

YTD
+4.5%
+4.5%
1 Month
+8.3%
+8.3%
3 Month
+13.2%
+13.2%
6 Month
+8.6%
+8.6%
1 Year
+7.9%
+7.9%

More News

Read More
Avadel Pharmaceuticals Soars as Alkermes Announces $2.1 Billion Acquisition
Via MarketMinute
Topics Intellectual Property
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avadel Pharmaceuticals plc (Nasdaq – AVDL), Middlefield Banc Corp. (Nasdaq – MBCN), Heidrick & Struggles International, Inc. (Nasdaq - HSII), Comerica Incorporated
From Brodsky & Smith LLC
Via GlobeNewswire
Avadel Jumps On $2.1 Billion Takeover Deal. But Buyer, Alkermes, Dives.
Via Investor's Business Daily
Avadel Stock Rises After Acquisition Offer By Alkermes
Via Stocktwits
9 Analysts Assess Alkermes: What You Need To Know
Via Benzinga
This Ciena Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Via Benzinga
Deep Dive Into Alkermes Stock: Analyst Perspectives (7 Ratings)
Via Benzinga
Earnings Scheduled For July 29, 2025
Via Benzinga
Alkermes Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Via Benzinga
Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
This Unisys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga
Bruker, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
ALKERMES PLC (NASDAQ:ALKS) Emerges as a Top Value Pick with Strong Fundamentals and Undervalued Metrics
Via Chartmill
Alkermes PLC (NASDAQ:ALKS) Surges 7.8% Pre-Market After Q2 2025 Earnings Beat Revenue and EPS Estimates
Via Chartmill
Topics Earnings
Alkermes Q2 Sales Up 14 Percent
Via The Motley Fool
Topics Intellectual Property
Alkermes Offers The Next Proof Point For Its Narcolepsy Approach. Stock Dives.
Via Investor's Business Daily
Alkermes Oral Drug Helps Patients Stay Awake In Mid-Stage Sleep Disorder Study
Via Benzinga
Expert Outlook: Alkermes Through The Eyes Of 6 Analysts
Via Benzinga
Biogen Shares Slip After $46M Research Charge Hits Quarterly Profit
Via Stocktwits
ALKERMES PLC (NASDAQ:ALKS) – A Potential Undervalued Opportunity in Biopharma
Via Chartmill
Nvidia To Rally More Than 38%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
This Cooper Companies Analyst Turns Bullish; Here Are Top 3 Upgrades For Tuesday
Via Benzinga
Alkermes Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Via Benzinga

Frequently Asked Questions

Is Alkermes plc - Ordinary Shares publicly traded?
Yes, Alkermes plc - Ordinary Shares is publicly traded.
What exchange does Alkermes plc - Ordinary Shares trade on?
Alkermes plc - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Alkermes plc - Ordinary Shares?
The ticker symbol for Alkermes plc - Ordinary Shares is ALKS on the Nasdaq Stock Market
What is the current price of Alkermes plc - Ordinary Shares?
The current price of Alkermes plc - Ordinary Shares is 30.04
When was Alkermes plc - Ordinary Shares last traded?
The last trade of Alkermes plc - Ordinary Shares was at 10/23/25 04:00 PM ET
What is the market capitalization of Alkermes plc - Ordinary Shares?
The market capitalization of Alkermes plc - Ordinary Shares is 4.99B
How many shares of Alkermes plc - Ordinary Shares are outstanding?
Alkermes plc - Ordinary Shares has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.